Insertion sites for recombinant vaccinia virus construction: Effects on expression of a foreign protein

Journal of General Virology

Volumn 81, Issue 2, 2000, Pages 431-439

  Coupar, Barbara E H ^a   Oke, Pamela G ^a   Andrew, Marion E ^a  

^a CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; LUCIFERASE; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ARTICLE; GENE DISRUPTION; GENE INSERTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINIA; VACCINIA VIRUS; VIRUS GENE; VIRUS RECOMBINANT;

ANIMALIA; DNA VIRUSES; HERPES; MURINAE; SIMPLEXVIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0033980605     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-2-431     Document Type: Article

References (26)

1. Andrew, M. E. & Coupar, B. E. H. (1992). Biological effects of recombinant vaccinia virus-expressed interleukin 4. Cytokine 4, 281-286.
2. Andrew, M. E., Coupar, B. E. H., Ada, G. L. & Boyle, D. B. (1986). Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. Microbial Pathogenesis 1, 443-452.
3. Andrew, M. E., Boyle, D. B., Coupar, B. E. H., Whitfeld, P. L., Both, G. W. & Bellamy, A. R. (1987). Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies. Journal of Virology 61, 1054-1060.
4. Andrew, M. E., Coupar, B. E. H. & Boyle, D. B. (1989). Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice. Immunology and Cell Biology 67, 331-337.
5. Bembridge, G. P., Lopez, J. A., Cook, R., Melero, J. A. & Taylor, G. (1998). Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-spedfic memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon. Journal of Virology 72, 4080-4087.
6. Bennett, A. M., Lescott, T., Phillpotts, R. J., Mackett, M. & Titball, R. W. (1999). Recombinant vaccinia viruses protect against Clostridium perfringens α-toxin. Viral Immunology 12, 97-105.
7. Boyle, D. B., Coupar, B. E. H. & Both, G. W. (1985). Multiple cloning site plasmids for the rapid construction of recombinant poxviruses. Gene 35, 169-177.
8. Buller, R. M., Smith, G. L., Cremer, K., Notkins, A. L. & Moss, B. (1985). Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317, 813-815.
9. Cameron, F. H. & Jennings, P. A. (1989). Specific gene suppression by engineered ribozymes in monkey cells. Proceedings of the National Academy of Sciences, USA 86, 9139-9143.
10. Coupar, B. E. H., Boyle, D. B. & Both, G. W. (1987). Effect of in vitro mutation in vaccinia virus early promoter region monitored by herpes simplex virus thymidine kinase expression in recombinant vaccinia virus. Journal of General Virology 68, 2299-2309.
11. Coupar, B. E. H., Andrew, M. E. & Boyle, D. B. (1988). A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. Gene 68, 1-10.
12. Davison, A. J. & Moss, B. (1989). Structure of vaccinia virus early promoters. Journal of Molecular Biology 210, 749-769.
13. Flexner, C., Hugin, A. & Moss, B. (1987). Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression. Nature 330, 259-262.
14. Goebel, S. J., Johnson, G. P., Perkus, M. E., Davis, S. W., Winslow, J. P. & Paoletti, E. (1990). The complete DNA sequence of vaccinia virus. Virology 179, 247-266.
15. Karupiah, G., Coupar, B., Ramshaw, I., Boyle, D., Blanden, R. & Andrew, A. (1990). Vaccinia virus-mediated damage of murine ovaries and protection by virus-expressed interleukin-2. Immunology and Cell Biology 68, 325-333.
16. Kunke, D., Broucek, J., Kutinova, L., Nemeckova, S., Ludvikova, V., Strnad, I., Kramosil, J., Nemcova, J., Schramlova, J., Simonova, V. & Vonka, V. (1993). Vaccinia virus recombinants coexpressing hepatitis B virus surface and core antigens. Virology 195, 132-139.
17. Mackett, M., Smith, G. L. & Moss, B. (1984). General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49, 857-864.
18. Morrison, H. G., Goldsmith, C. S., Regnery, H. L. & Auperin, D. D. (1990). Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus. Virus Research 18, 231-242.
19. Moss, B. & Flexner, C. (1987). Vaccinia virus expression vectors. Annual Review of Immunology 5, 305-324.
20. Paoletti, E. (1990). Poxvirus recombinant vaccines. Annals of the New York Academy of Science 590, 309-325.
21. Perkus, M. E., Piccini, A., Lipinkas, B. R. & Paoletti, E. (1985). Recombinant vaccinia virus: immunization against multiple pathogens. Science 229, 981-984.
22. Ramshaw, I. A., Andrew, M. E., Phillips, S. M., Boyle, D. B. & Coupar, B. E. H. (1987). Immunodeficient mice recover from a vaccinia virus-IL2 recombinant infection. Nature 329, 545-546.
23. Rhim, J. S., Cho, H. Y. & Huebner, R. J. (1975). Non-producer human cells induced by murine sarcoma virus. International Journal of Cancer 15, 23-29.
24. Roseman, N. A. & Slabaugh, M. B. (199O). The vaccinia virus HindIII F fragment: nucleotide sequence of the left 62 kb. Virology 178, 410-418.
25. Smith, G. L & Mackett, M. (1992). The design, construction and use of vaccinia virus recombinants. In Recombinant Poxviruses, pp. 81-122. Edited by M. M. Binns & G. L. Smith. Boca Raton, FL: CRC Press.
26. Wild, T. F., Bernard, A., Spehner, D. & Drillien, R. (1992). Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. Journal of General Virology 73, 359-367.